| Dr Brandon Nolte, PHARMD | |
|
17239 Five Points Sq, Lewes, DE 19958-1699 | |
| (302) 644-7840 | |
| Not Available |
| Full Name | Dr Brandon Nolte |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 17239 Five Points Sq, Lewes, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053697045 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | A1-0004054 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brandon Nolte, PHARMD 17239 Five Points Sq, Lewes, DE 19958-1699 Ph: () - | Dr Brandon Nolte, PHARMD 17239 Five Points Sq, Lewes, DE 19958-1699 Ph: (302) 644-7840 |
News Archive
An ultra-fast, 320-detector computed tomography (CT) scanner can accurately sort out which people with chest pain need - or don't need - an invasive procedure such as cardiac angioplasty or bypass surgery to restore blood flow to the heart, according to an international study. Results of the study, which involved 381 patients at 16 hospitals in eight countries, are scheduled to be presented at the European Society of Cardiology Congress in Munich, Germany, on August 28.
A study appearing in the July 2010 issue of Anesthesiology is the first to show that inhalation of gaseous hydrogen sulfide can reduce or even prevent lung injury in critical care situations that require mechanical ventilation.
Autism Speaks, the world's largest autism science and advocacy organization, together with First Signs, a leader in educating parents and professionals about the early signs of autism and related disorders, and Florida State University's Autism Institute today announced the launch of a new treatment section of its acclaimed online Autism Video Glossary, giving parents an important new tool as they work to determine the best treatment options for their child.
Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
› Verified 9 days ago
Keili Marvel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17239 Five Points Sq, Lewes, DE 19958 Phone: 302-448-1386 | |
Dilip John Daniel, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17239 Five Points Sq, Lewes, DE 19958 Phone: 302-644-7840 Fax: 302-644-7844 | |
Dr. William Paul Albanese Iii, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 424 Savannah Rd, Pharmacy Department, Lewes, DE 19958 Phone: 302-645-3224 | |
Elizabeth Darbee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3100 | |
William Trifillis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 444 Savannah Rd, Lewes, DE 19958 Phone: 302-645-6243 Fax: 302-645-6910 | |
Padraic Keen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3100 |